ctrl K

Watchlist Price Alert

Silexion Therapeutics LTD (SLXN)

NASDAQ: SLXN · Real-Time Price · USD

0.98

-0.04 (-3.92%)

At close: May 06, 2025, 3:57 PM

1.04

5.81%

Pre-market: May 07, 2025, 06:25 AM EDT

Silexion Therapeutics LTD Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-12.57M	-12.4M	-5.09M	-3.86M	-2.62M	-887.28K	-156.28K	-808
Interest Income	25K	58K	58K	370K	351K	318K	318K	n/a
Pretax Income	-16.51M	-16.44M	-5.38M	-3.73M	-2.31M	-640.78K	162.22K	-733
Net Income	-16.44M	-16.42M	-5.36M	-3.73M	-2.35M	-624.83K	162.17K	-774
Selling & General & Admin	6.75M	6.18M	1.54M	1.09M	806.6K	341.6K	155.6K	127.00
Research & Development	5.82M	6.2M	3.52M	2.75M	1.79M	535.68K	681.00	681.00
Other Expenses	3K	21K	31K	24K	16K	10K	n/a	n/a
Operating Expenses	12.57M	12.4M	5.09M	3.86M	2.62M	887.28K	156.28K	808.00
Interest Expense	2K	-41K	-41K	-43K	-43K	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	12.57M	12.4M	5.09M	3.55M	2.3M	576.34K	-154.66K	808.00
Income Tax Expense	10K	15K	19K	17K	12.01K	6.01K	10.00	10.00
Shares Outstanding (Basic)	1.85M	8.15M	8.15M	8.15M	8.15M	8.15M	660.51K	8.15M
Shares Outstanding (Diluted)	1.85M	8.15M	8.15M	8.15M	8.15M	8.15M	660.51K	8.15M
EPS (Basic)	-2.01	-2.01	-0.66	-0.23	-0.06	0.15	0.25	-0.00
EPS (Diluted)	-2.01	-2.01	-0.66	-0.45	-0.28	-0.07	0.03	-0.00
EBITDA	-16.58M	-12.46M	-5.16M	-3.52M	-2.28M	-558.85K	162.16K	-793
EBIT	-16.6M	-12.5M	-5.19M	-3.55M	-2.3M	-568.86K	162.14K	-808
Depreciation & Amortization	25K	43K	31K	24K	16.02K	10.02K	15.00	15.00